A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

NCT00238654 · clinicaltrials.gov ↗
COMPLETED
Status
257
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Teva Neuroscience, Inc.